Court Dismisses Novartis Challenge to Indian Patent Law

BMJ
doi 10.1136/bmj.39301.420012.db
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

“To Patent or Not to Patent? The Case of Novartis’ Cancer Drug Glivec in India”

Globalization and Health
Health PolicyPublic HealthOccupational HealthEnvironmental
2014English

American Patent Law System.

Nature
Multidisciplinary
1932English

Medicolegal: First Successful Court Challenge to GMC Charges

BMJ
1985English

Panel Asked to Rule on US–Indian Patent Row

Nature
Multidisciplinary
1996English

Patent Issues in Indian Pharmaceutical Industry

International Journal of Modern Trends in Engineering & Research
2017English

Public Enforcement of Patent Law

SSRN Electronic Journal
2015English

Unauthorized Practice of Law: Supreme Court Holds States Cannot Restrict Authorized Activities of Nonlawyer Patent Office Practitioner

Duke Law Journal
Law
1964English

Physicality in Australian Patent Law

Deakin Law Review
2011English

Canada's Supreme Court Abolishes ‘Promise of the Patent’

Pharmaceutical patent analyst
MedicineDrug DiscoveryPharmaceutical Science
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy